Innate Pharma SA
SWB:IDD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
Cineverse Corp
NASDAQ:CNVS
|
US |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
|
P2Earn Inc
F:WH4
|
CA |
|
S
|
Standard Bank Group Ltd
XMUN:SKC2
|
ZA |
|
ProPetro Holding Corp
NYSE:PUMP
|
US |
|
O
|
Oracle Corp
BMV:ORCL
|
US |
|
N
|
National Australia Bank Ltd
SWB:NAL
|
AU |
|
G
|
General Electric Co
XETRA:GCP
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
S
|
Shin-Etsu Chemical Co Ltd
SWB:SEH
|
JP |
|
M
|
Meta Platforms Inc
F:FB2A
|
US |
|
Aztec Minerals Corp
XTSX:AZT
|
CA |
|
Fidia SpA
MIL:FDA
|
IT |
|
S1 Corp
KRX:012750
|
KR |
|
Aena SME SA
F:A440
|
ES |
|
J
|
J Sainsbury PLC
DUS:SUY1
|
UK |
|
F
|
Federated Hermes Inc
F:3KC
|
US |
|
Chemours Co
NYSE:CC
|
US |
|
C
|
Croda International PLC
F:6CMB
|
UK |
|
Malin Corporation PLC
OTC:MLLNF
|
IE |
Multiples-Based Value
The Multiples-Based Value for
Innate Pharma SA (IDD) under the Base Case is hidden
EUR.
Compared with the current market price of 1.598 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.